Watzke H H
Department of Medicine, University of Vienna, Austria.
Thromb Haemost. 1999 Sep;82 Suppl 1:124-6.
A number of studies have been published in the last years which shed light on the optimal intensity and the optimal duration of oral anticoagulation in patients with venous thrombosis. Based on these studies it is now generally recommended to treat patients with venous thromboembolism at an INR ranging from 2.0 to 3.0. The optimal duration of anticoagulation mainly depends on the nature of the thrombotic event. In patients with a temporary prothrombotic risk factor such as surgery, immobilization or trauma a relatively short duration of oral anticoagulation (3-6 months) is generally recommended. Patients with idiopathic venous thromboembolism require a considerably longer duration of anticoagulation (6 months at least).
在过去几年里发表了多项研究,这些研究揭示了静脉血栓形成患者口服抗凝治疗的最佳强度和最佳持续时间。基于这些研究,目前普遍建议对静脉血栓栓塞患者进行治疗时,国际标准化比值(INR)应在2.0至3.0之间。抗凝治疗的最佳持续时间主要取决于血栓形成事件的性质。对于有临时促血栓形成危险因素(如手术、制动或创伤)的患者,一般建议口服抗凝治疗的持续时间相对较短(3至6个月)。特发性静脉血栓栓塞患者需要相当长的抗凝治疗时间(至少6个月)。